Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials.
Sealonix has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in May 2023.
Sealonix's investors include J2 Ventures, Excelestar Ventures, TiE-Boston, AMED Ventures, Sparta Group.
Sealonix is headquartered in Bedford, United States.
Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials.
Sealonix is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sealonix — Funding & Investors." VCBacked, May 12, 2023, https://www.vcbacked.co/company/sealonix. Accessed July 31, 2026.
VCBacked. (2023). Sealonix — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/sealonix
{{cite web |title=Sealonix — Funding & Investors |url=https://www.vcbacked.co/company/sealonix |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated